For research teamsHelp me find a study
Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
262studies shown
Showing 73-84 of 262
Drug study icon
Not recruitingEUCTR 2008-001581-91

A Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
France, United Kingdom, Germany, ...
Sponsor
Takeda Global Research & Development Centre (Europe) Ltd.
Condition
Depression
View study
Drug study icon
Not recruitingEUCTR 2006-004716-48

Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder. A 6-week randomised, double-blind parallel groups study versus ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
France, United Kingdom, Austria, ...
Sponsor
Institut de Recherches Internationales Servier
Condition
Depression
View study
Other study type icon
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed in the United States, in France, in Canada, .... It focuses on depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
View study
Drug study icon
TerminatedNCT05518149

Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)

This study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Australia, France, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
View study
Device study icon
CompletedNCT01973478

Deep Brain Stimulation in people with Chronic Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
France
Sponsor
Rennes University Hospital
Condition
Depression, Bipolarity
View study
Drug study icon
CompletedNCT03097133

Intranasal Esketamine for depression

This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.

In France
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
View study
Drug study icon
TerminatedNCT06635135

Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression

This study was terminated in the United States, in France, in Belgium, .... It is testing aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, France, Belgium, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
View study
Drug study icon
CompletedNCT03227224

JNJ-42847922 for depression

This study is completed in the United States, in France, in Bulgaria, .... It is testing JNJ-42847922 for depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
View study
Drug study icon
CompletedNCT03185819

3 Fixed Doses of Intranasal Esketamine for depression

This study is completed in the United States, in France, in Belgium, .... It is testing 3 Fixed Doses of Intranasal Esketamine for depression.

In France
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 9 Years to 17 Years
Countries
United States, France, Belgium, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
View study
Drug study icon
CompletedNCT02417064

Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in Canada, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.